West Pharmaceutical Services, Inc.

NYSE:WST

Medical - Instruments & Supplies

Healthcare
$404.02 +1.56%

+$5.04 today

Market cap
$28.14B
Beta
1.18
P/E (TTM)
43.6
EPS (TTM)
$7.54
Dividend yield
0.26%
52W Low $206.80High $336.82

Volume 0.59M

Average 0.85M

WST Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

West Pharmaceutical Services, Inc.NYSE: WST

Net Margin · Q2 FY2026 · quarter ended Jun 2026

Net margin holds steady near 17.7%

Net margin was 17.7% in Q2 FY2026, up 0.5 pp from a year earlier. On a trailing-twelve-month basis it was 17.0%, up 0.5 pp year over year. Over 3 fiscal years it narrowed by 4.2 pp.

Context

  • Net margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 12 analysts of 19.8% for the fiscal year ending Dec 2026, up from 16.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
17.7%+1.2 pp QoQ
Last fiscal yearDec 2025
16.1%-1.0 pp YoY
LTMJun 2026
17.0%+0.5 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+0.5 pp+1.4 pp+1.0 pp
1 year-1.0 pp+3.7 pp+4.7 pp
3 years-4.2 pp+5.1 pp+9.4 pp
5 years+7.8 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
16.1%
Year-over-year change
-1.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How WST compares with its peers on the latest reported figures

  • WST's LTM Jun 2026 net margin of 17.0% is the highest of the 5 companies compared; the peer median is 5.3%.
  • Its year-over-year change of +0.5 pp is the 3rd highest of 5, against a peer median of +1.1 pp.
  • Over three fiscal years its change of -4.2 pp compares with a peer median of +3.2 pp.
WST Competitors Peer median
Net Margin for WST and competitors
Company Period LTM level YoY 3-year change
WSTWest Pharmaceutical Services, Inc.LTM Jun 202617.0% +0.5 pp-4.2 pp
STVNStevanato Group S.p.A.LTM Jun 202611.0% -0.8 pp-2.7 pp
ATRAptarGroup, Inc.LTM Jun 20269.2% -1.6 pp+3.2 pp
ICUIICU Medical, Inc.LTM Jun 20261.4% +3.0 pp+3.3 pp
BLFSBioLife Solutions, Inc.LTM Mar 2026-10.5% +4.2 pp+170.8 pp
Peer median (excluding WST) 5.3%+1.1 pp+3.2 pp

Competitors are the stored peer set for WST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.83B2.89B2.95B2.89B3.07B
Cost of Revenue1.66B1.75B1.82B1.89B1.97B
Gross Profit1.17B1.14B1.13B1B1.1B
Gross Margin41.5%39.5%38.4%34.6%35.9%
Research & Development52.8M58.5M68.4M69.1M74.3M
Selling, General & Admin361.9M316.9M353.4M338.5M393.1M
Operating Expenses414.7M375.4M421.8M407.6M485.9M
Depreciation & Amortization122.3M120.6M137.3M155.4M171.4M
EBITDA879.7M808.1M844.1M743.8M770.6M
EBITDA Margin31.1%28.0%28.6%25.7%25.1%
Operating Income758.7M763.5M710.9M594.6M617.4M
Operating Margin26.8%26.5%24.1%20.6%20.1%
Interest Income1M5.1M28M19.6M17.7M
Interest Expense8.5M7.6M8.8M2.9M600K
Other Income / Expenses10.3M(62.9M)4.8M5.6M(2.1M)
Income Before Tax769M700.6M715.7M600.2M615.3M
Pre-Tax Margin27.2%24.3%24.3%20.7%20.0%
Income Tax Expense107.2M114.7M122.3M107.5M121.6M
Net Income661.8M585.9M593.4M492.7M493.7M
Net Margin23.4%20.3%20.1%17.0%16.1%
EPS (Basic)8.907.887.996.756.83
EPS (Diluted)8.677.737.886.696.80
Weighted Avg Shares74.4M74.4M74.3M73M72.3M
Weighted Avg Shares (Diluted)76.3M75.8M75.3M73.7M72.7M

West Pharmaceutical Services, Inc.

NYSE:WST

Intrinsic Alpha fair value

Locked

Current Price

$404.02

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.